CNCF 2010 ~ Dr Peter Zage on 3F8 phase II randomized trial
Dr Peter Zage from MD Anderson in Houston TX gave a presentation at the Children’s Neuroblastoma Cancer Foundation (CNCF) conference Saturday July 10, 2010 on the 3F8 randomized trial: A Study of...
View ArticleTwo new phase 2 frontline 3F8 trials open at Memorial Sloan-Kettering in NY
High-dose 3F8 trials for high-risk neuroblastoma in first remission High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission After Non-Myeloablative Therapy in...
View ArticleMore high-dose 3F8 trials open, one 3F8 trial closed
Memorial-Sloan Kettering (MSKCC) has opened two more high-dose 3F8 trials for neuroblastoma High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of Second or Greater Remission...
View ArticleClik here to view.
Latest neuroblastoma related news
Neuroblastoma bits from November 2010 . Excellent new review article on anti-GD2 antibodies Just published by Yang and Sondel, this thorough review tracks the evolution of antibodies for neuroblastoma...
View ArticleNew antibody trials in 2011
Antibodies for relapsed neuroblastoma Given that recent studies such as COG-3973 [1] and others reveal that half or more of all children with high-risk neuroblastoma are refractory to induction or...
View ArticleHu3F8 is now a reality at Memorial-Sloan Kettering
The Story of the Band of Parents and humanized 3F8 by Caryn Franca and Shirley Staples It was summer of 2007. A group of parents had asked Dr. Nai-Kong Cheung to meet and update them on new treatments...
View Article
